Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-09 7:14 pm Sale | 13G | LUMOS PHARMA INC LUMO | GOLDMAN SACHS GROUP INC GS | 406,711 5.1% | -62,691 (-13.36%) | View |
| 2024-02-06 09:57 am Purchase | 13G | LUMOS PHARMA INC LUMO | WELLS FARGO & COMPANY WFC | 417,051 5.3% | 417,051 (New Position) | View |
| 2023-11-29 4:30 pm Sale | 13D | NEWLINK GENETICS CORP NLNK | Blackstone Holdings II L.P. | 385,683 4.9% | -82,462 (-17.61%) | View |
| 2023-06-20 06:05 am Sale | 13D | LUMOS PHARMA INC LUMO | Farb Daniel Stuart | 400,000 4.9% | -96,891 (-19.50%) | View |
| 2023-06-02 11:14 am Sale | 13D | LUMOS PHARMA INC LUMO | Farb Daniel Stuart | 496,891 6.08% | -146,447 (-22.76%) | View |
| 2023-05-25 12:10 pm Sale | 13D | LUMOS PHARMA INC LUMO | Farb Daniel Stuart | 643,338 7.87% | -116,662 (-15.35%) | View |
| 2023-02-14 6:25 pm Unchanged | 13D | LUMOS PHARMA INC LUMO | Farb Daniel Stuart | 760,000 9.07% | 0 (Unchanged) | View |
| 2023-02-06 5:43 pm Purchase | 13G | LUMOS PHARMA INC LUMO | GOLDMAN SACHS GROUP INC GS | 469,402 5.6% | 469,402 (New Position) | View |
| 2023-01-24 12:58 pm Purchase | 13G | LUMOS PHARMA INC LUMO | Farb Daniel Stuart | 760,000 9.07% | 263,189 (+52.98%) | View |
| 2022-02-02 2:44 pm Unchanged | 13G | LUMOS PHARMA INC LUMO | Farb Daniel Stuart | 496,811 5.94% | 0 (Unchanged) | View |
| 2022-01-31 5:34 pm Purchase | 13G | LUMOS PHARMA INC LUMO | Farb Daniel Stuart | 496,811 5.94% | 496,811 (New Position) | View |
| 2022-01-05 2:41 pm Sale | 13D | LUMOS PHARMA INC LUMO | New Enterprise Associates 14 L.P. | 0 0% | -524,030 (Position Closed) | View |
| 2021-08-30 5:21 pm Purchase | 13D | LUMOS PHARMA INC LUMO | SHV Management Services II LP | 679,909 8.1% | 679,909 (New Position) | View |
| 2021-05-26 3:53 pm Sale | 13G | LUMOS PHARMA INC LUMO | Flynn James E | 161,714 1.94% | -774,577 (-82.73%) | View |
| 2021-02-12 3:56 pm Purchase | 13G | LUMOS PHARMA INC LUMO | Lion Point Capital LP | 407,192 4.9% | 407,192 (New Position) | View |
| 2021-02-12 12:28 pm Purchase | 13G | LUMOS PHARMA INC LUMO | Flynn James E | 936,291 11.28% | 122 (+0.01%) | View |
| 2021-02-10 7:04 pm Purchase | 13G | LUMOS PHARMA INC LUMO | RENAISSANCE TECHNOLOGIES LLC | 308,812 3.72% | 308,812 (New Position) | View |
| 2020-03-31 5:48 pm Purchase | 13D | LUMOS PHARMA INC LUMO | New Enterprise Associates 14 L.P. | 524,030 6.3% | 524,030 (New Position) | View |
| 2020-03-30 5:26 pm Purchase | 13D | NEWLINK GENETICS CORP NLNK | Blackstone Holdings II L.P. | 468,145 5.6% | 468,145 (New Position) | View |
| 2020-02-18 10:06 am Sale | 13G | NEWLINK GENETICS CORP NLNK | Link Jr. Charles J | 690,531 1.8% | -1,776,108 (-72.01%) | View |